Shernan Holtan, MD, is a physician-scientist and hematologist-oncologist specializing in blood and marrow transplantation. She serves as Chief of the Blood and Marrow Transplantation Section and Professor of Medicine at Roswell Park Comprehensive Cancer Center. Clinically, Dr. Holtan focuses on blood and marrow transplantation, cellular immunotherapy, and transplant survivorship and supportive care. Her research centers on transplant immunology and immune tolerance, cellular and regenerative therapies to enhance graft success and tissue repair, and the role of nutrition and strength conditioning in post-transplant recovery. She has been recognized with the Lukas D. Wartman Award by the GVHD Alliance and helped lead an FDA orphan drug designation for a repurposed therapy addressing a critical transplant complication. Dr. Holtan serves as co-chair of the ASTCT Committee on Content and previously directed the Clinical Trials Office for the Cell, Gene, and Immunotherapy Program at the Masonic Cancer Center. She earned her MD from the University of Nebraska Medical Center and completed residency in Internal Medicine and fellowship training in Hematology, Oncology, and Blood and Marrow Transplantation at the Mayo Clinic in Rochester, Minnesota.
Professor
Medical School
1999 – 2003
Residency
2003 – 2006
Fellowship
2006 – 2011